Publication | Closed Access

A novel VIM‐type metallo‐beta‐lactamase (VIM‐14) in a Pseudomonas aeruginosa clinical isolate from a neonatal intensive care unit

Medical MicrobiologyAntimicrobial Drug DiscoveryAntimicrobial SusceptibilityAntimicrobial Resistance GeneAntibioticsMicrobiologyInfection ControlMedicineBacterial PathogensClinical MicrobiologyAntimicrobial ResistanceNovel Vim‐type Metallo‐beta‐lactamase